Поиск по репозиторию
Статья
Emerging manufacturers engagements in the COVID −19 vaccine research, development and supply
2021
The World Health Organization declared the COVID-19 disease as a pandemic requiring a rapid response. Through online search, direct communication with network members and an internal survey, engagements of developing countries’ vaccine manufacturers’ network members in the research and development of COVID-19 vaccines and their capacities in the manufacturing, fill-finish and distribution of vaccines were assessed. Currently, 19 network members engaged in research and development of COVID-19 vaccines, using six principal technology platforms. In addition, an internal survey showed that the number of vaccines supplied collectively by 37 members, in 2018–19, was about 3.5 billion doses annually. Almost a third of network members having vaccines prequalified by the World Health Organization comply with international regulations and mechanisms to distribute vaccines across borders. The use of existing manufacturing, fill-finish and distribution capabilities can support an efficient roll-out of vaccines against COVID-19, while maintaining supply security of existing vaccines for on-going immunization programmes. © 2020 The Author(s)
Цитирование
Похожие публикации
Версии
- 1. Version of Record от 2021-04-27
Метаданные
Название журнала
- Vaccine
Том
- 38
Выпуск
- 34
Страницы
- 5418-5423
Ключевые слова
- coronavirus disease 2019 vaccine; severe acute respiratory syndrome vaccine; unclassified drug; COVID-19 vaccine; virus vaccine; Article; coronavirus disease 2019; drug efficacy; global health; human; immunity; pandemic; priority journal; Severe acute respiratory syndrome coronavirus 2; standard; vaccination; vaccine immunogenicity; vaccine production; World Health Organization; clinical trial (topic); Coronavirus infection; drug industry; immunology; international cooperation; medical research; organization and management; pandemic; virus pneumonia; Biomedical Research; Clinical Trials as Topic; Coronavirus Infections; Drug Industry; Humans; International Cooperation; Pandemics; Pneumonia, Viral; Viral Vaccines; World Health Organization
Издатель
- Elsevier Ltd
Тип документа
- journal article
Тип лицензии Creative Commons
- CC
Правовой статус документа
- Свободная лицензия
Источник
- scopus
